Thus, blockage of the bFGF/FGFR3/RSK2 signaling axis by kaempferol may inhibit the progressive structural damage of RA joints that is induced by overwhelming osteoclast activity. This evidence concerns the gene FGFR3 and rheumatoid arthritis.